Article Text
Statistics from Altmetric.com
Case description
A 61-year-old African–American man presented 1 hour after the onset of left-sided limb weakness and facial numbness. He was taking an ACE inhibitor for hypertension. One year before, he had developed an ischaemic left basal ganglia stroke, having presented 48 hours after the onset of symptoms. He had been medically managed with aspirin and high-intensity statin only and had recovered with no residual deficit.
On this second presentation he met the criteria for administration of alteplase (recombinant tissue plasminogen activator, tPA). …
Footnotes
Contributors Both listed authors have contributed to the drafting and writing of this article, as well as the care of the patient.
Competing interests None declared.
Patient consent for publication Obtained.
Provenance and peer review Not commissioned; externally peer reviewed by Anthony Pereira, London, UK.
Read the full text or download the PDF:
Other content recommended for you
- Hypersensitivity reactions to recombinant tissue plasminogen activator
- Unilateral tongue swelling: an unusual presentation of angiotensin-converting enzyme inhibitor-related angioedema
- Angioneurotic orolingual oedema following thrombolysis in acute ischaemic stroke
- Incidence, predictors and clinical characteristics of orolingual angio-oedema complicating thrombolysis with tissue plasminogen activator for ischaemic stroke
- ACE-inhibitor induced angio-oedema treated with complement C1-inhibitor concentrate
- A case of airway compromise
- Double trouble: tPA-induced angioedema
- Orolingual angio-oedema after alteplase therapy in a stroke patient concurrently using angiotensin II receptor blocker
- ‘Epinephrine-resistant’ angioedema
- ACE inhibitor induced visceral angioedema: an elusive diagnosis